AstraZeneca hopes the world can focus on its positive vaccine news. But experts fear a lack of transparency has clouded that
(CNN)When the British-Swedish drugmaker AstraZeneca announced on Monday that its experimental coronavirus vaccine is 70% effective on average, the world exhaled a collective sigh of relief and stocks rallied. Another vaccine with promising results had arrived.
But a lack of clarity surrounding several aspects of the data from the AstraZeneca vaccine trials have raised some eyebrows in the scientific community, potentially setting back the timing for the vaccine to be authorized in Europe and the US.
AstraZeneca said on Monday that study participants in the UK had been given two different courses of the vaccine.
banter and General Discussion, page-1926
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
0.085(7.83%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.12 | $1.20 | $1.11 | $10.37M | 8.889M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 100262 | $1.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 14869 | 4 |
View Market Depth
| Last trade - 11.56am 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.17 |
Change
0.085 ( 7.47 %) |
||||
| Open | High | Low | Volume | ||
| $1.12 | $1.20 | $1.12 | 2252409 | ||
| Last updated 12.11pm 06/05/2024 ? | |||||
| MSB (ASX) Chart |